Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intrahepatic Cholangiocarcinoma (ICC)”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Testing effectiveness (Phase 2)Temporarily pausedNCT03779100
What this trial is testing

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shi Ming 25
Large-scale testing (Phase 3)Looking for participantsNCT05342194
What this trial is testing

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 480
Testing effectiveness (Phase 2)UnknownNCT04454905
What this trial is testing

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 50
Not applicableLooking for participantsNCT07337850
What this trial is testing

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

Who this might be right for
Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)
Tata Memorial Centre 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152769
What this trial is testing

Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 104
Testing effectiveness (Phase 2)Looking for participantsNCT05678270
What this trial is testing

ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (ICC)
Beijing InnoCare Pharma Tech Co., Ltd. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648525
What this trial is testing

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Harbin Medical University 68
Large-scale testing (Phase 3)UnknownNCT03771846
What this trial is testing

HAIC Versus Systemic Chemotherapy for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shi Ming 188
Not applicableLooking for participantsNCT06735560
What this trial is testing

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Neuroendocrine Tumors
Nantes University Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946849
What this trial is testing

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital 76
Large-scale testing (Phase 3)UnknownNCT03940378
What this trial is testing

Treatment of Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
ICC
The First Affiliated Hospital of Zhengzhou University 152
Not applicableUnknownNCT01917370
What this trial is testing

VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway

Who this might be right for
Intrahepatic Cholangiocarcinoma
First Affiliated Hospital, Sun Yat-Sen University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07063888
What this trial is testing

A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Adjuvant ChemoradiotherapyNarrow Margin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 66
Testing effectiveness (Phase 2)Looking for participantsNCT06721286
What this trial is testing

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT05220722
What this trial is testing

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Who this might be right for
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
TriSalus Life Sciences, Inc. 23
Testing effectiveness (Phase 2)UnknownNCT03633773
What this trial is testing

Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 9
Not applicableUnknownNCT02184871
What this trial is testing

Next Generation Sequencing in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University of Bologna 45
Not applicableLooking for participantsNCT06862934
What this trial is testing

Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Load More Results